Constructing, developing, or upgrading pharmaceutical and biotech manufacturing facilities, laboratories, and equipment
Included in ACT-ID SUM-OF-ALL
Previously: ACT-A-A1FK2M, ACT-A-T4RWAC (v0 legacy ID)
This ACT-U is used in these taxonomies 2
Each row is a taxonomy that binds this use-of-proceeds to one or more objectives. The coloured tags show the value-chain role (direct / enabling / transitional), the contribution sign (positive / neutral / negative), and the taxonomy's traffic-light classification where applicable.
Climate Resilience - Resilient Industry & Commerce economic_development
direct positive
Climate Resilience - Resilient Industry & Commerce economic_development
direct positive
Criteria 0
No criteria records yet.
Related activities in other taxonomies 1
When two taxonomies describe closely-related activities that aren't identical, ACT-ID records the relationship here. Click any row to see the related activity.
Overlaps with this one is broader
Semantic mapping (confidence: 0.80): Constructing pharmaceutical & biotech facilities encompasses the manufacture of medicinal products but includes broader infrastructure development beyond just the manufacturing activity itself.